Guided Therapeutics, Inc. is a medical technology firm specializing in the creation of medical devices. Its primary focus is on bringing to market LuViva, an innovative device designed for the non-invasive detection of cervical cancer. This technology excels at identifying both cancerous and precancerous conditions of the cervix in a painless, non-invasive manner, directly at the point of care. LuViva operates by scanning the cervix with light and subsequently analyzing both the reflected and fluorescent light emitted. Established in 1992 and headquartered in Norcross, Georgia, the company was formerly known as SpectRx, Inc. until its rebranding to Guided Therapeutics, Inc. in February 2008.
Subscribe to see GUIDED THERAPEUTICS INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GUIDED THERAPEUTICS INC is a biotech company headquartered in Peachtree Corners, United States. It is publicly listed (GTHP) with a market capitalisation of $17.4M. Xcout tracks 5 named people at GUIDED THERAPEUTICS INC, including Mark L. Faupel (Chief Executive Officer, President, Chief Operating Officer, Acting Chief Financial Officer, Secretary & Director).
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $9.1M | — |
Financing after the IPO — public offerings and SEC Form D private placements — is not listed as a funding round.
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of GUIDED THERAPEUTICS INC's closest competitors — see the full list of competitors and alternatives →
CelLBxHealth plc is a medical diagnostics firm specializing in the creation of cancer detection solutions, with operations spanning the United Kingdom, broader Europe, North America, and other global markets. A flagship offering is the Parsortix PC1 system, a medical device engineered to isolate and collect whole circulating tumor cells (CTCs) from the blood of patients with metastatic breast cancer, preparing them for further user-validated analysis. The company also provides the Parsortix PR1 system for general CTC capture and collection from blood samples. Beyond its core systems, CelLBxHealth offers the Portrait+ CTC Staining kit, a laboratory solution designed for the precise identification, characterization, and quantification of both epithelial and mesenchymal circulating tumor cells, boasting strong analytical sensitivity and specificity. Another key product is the CellKeep Slide, which facilitates CTC harvesting. The company extends its expertise through various laboratory services, including advanced CTC enrichment and liquid biopsy analysis. Its assay portfolio comprises Portrait Flex, an immunofluorescence assay for detecting epithelial, mesenchymal, and epithelial-to-mesenchymal transition states, as well as assessing DNA damage response. Additionally, CelLBxHealth provides Portrait PD-L1 for CTC evaluation and develops customized CTC assays. Strategic collaborations underpin some of its development efforts; it has partnered with BioView Ltd to co-develop a human epidermal growth factor receptor 2 (HER2) assay kit for breast cancer, and an agreement with NuProbe USA, Inc. involves utilizing a pan-cancer next-generation sequencing (NGS) panel. Originally established in 1994 as ANGLE plc, the company rebranded to CelLBxHealth plc in October 2025 and operates from its base in Guildford, UK.
TopoDx, Inc. is a diagnostic company founded in 2024 and headquartered in Atlanta, Georgia. The company operates in the medical diagnostics sector.
Esperto Medical is a medical equipment manufacturing company headquartered in Fullerton, California, dedicated to developing revolutionary non-invasive diagnostic technologies for healthcare.
Femasys Inc. is a medical technology company headquartered in Suwanee, Georgia, focusing on women's health and specialized therapeutic and diagnostic solutions.
iSono Health, Inc. specializes in automated breast imaging technology and provides diagnostic tools such as its FDA-cleared ATUSA system.
Forward Science Holding Inc. is a medical technology company that develops and manufactures oral health products and screening devices, including oral cancer screening tools and periodontal treatments. The company serves dental professionals and clinical practices to improve patient oral care outcomes.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.